Account
iCubesWire bags Sanghi Cement mandate
MUMBAI: iCubesWire, a leading Digital Marketing Solution and concept provider, recently won the digital marketing mandate for Sanghi Cement, a brand name of Ravi Sanghi Group dealing in cement production and distribution in Western India. As part of the mandate, iCubesWire will drive and deliver the digital marketing requirements of Sanghi Cement. The digital marketing mandate covers social, search and media for Sanghi Cement.
Commenting on the association, Sahil Chopra, CEO & founder, iCubesWire said, “Sanghi Cement is a renowned brand in the cement industry and we are extremely happy to be associated with them. We aim to use our strategic and innovative solutions to enhance its brand connect. We look forward to a healthy partnership with Sanghi Cement.”
iCubesWire will manage social media marketing, digital advertising, search engine optimization and website design for Sanghi Cement, providing big ROI on the brand value.
Shailesh Jha, VP (Sales & Marketing), Sanghi Industries Ltd. says, “We wanted an agency that could provide us with innovative solutions and strategies to effectively reach out to our target audience. iCubesWire’s creative solutions gave us the confidence to have them onboard. iCubesWire has strong insights of the customer database and it’s out of the box approach will help us capture our potential market and yield positive results. We look forward to working with the team.”
According to FICCI Media & Entertainment Industry Report 2017, digital advertising has captured 15% share in the overall advertising revenues with 28% growth rate in 2016. It is projected to grow at a CAGR of 31% to reach Rs 294.5 billion by 2021, contributing 27.3% to the total advertising revenues.
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”







